Cargando…

Implementing essential diagnostics-learning from essential medicines: A scoping review

The World Health Organization (WHO) model list of Essential In vitro Diagnostic (EDL) introduced in 2018 complements the established Essential Medicines List (EML) and improves its impact on advancing universal health coverage and better health outcomes. We conducted a scoping review of the literatu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyanchoka, Moriasi, Mulaku, Mercy, Nyagol, Bruce, Owino, Eddy Johnson, Kariuki, Simon, Ochodo, Eleanor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121180/
https://www.ncbi.nlm.nih.gov/pubmed/36962808
http://dx.doi.org/10.1371/journal.pgph.0000827
_version_ 1785029328666361856
author Nyanchoka, Moriasi
Mulaku, Mercy
Nyagol, Bruce
Owino, Eddy Johnson
Kariuki, Simon
Ochodo, Eleanor
author_facet Nyanchoka, Moriasi
Mulaku, Mercy
Nyagol, Bruce
Owino, Eddy Johnson
Kariuki, Simon
Ochodo, Eleanor
author_sort Nyanchoka, Moriasi
collection PubMed
description The World Health Organization (WHO) model list of Essential In vitro Diagnostic (EDL) introduced in 2018 complements the established Essential Medicines List (EML) and improves its impact on advancing universal health coverage and better health outcomes. We conducted a scoping review of the literature on implementing the WHO essential lists in Africa to inform the implementation of the recently introduced EDL. We searched eight electronic databases for studies reporting on implementing the WHO EDL and EML in Africa. Two authors independently conducted study selection and data extraction, with disagreements resolved through discussion. We used the Supporting the Use of Research Evidence (SURE) framework to extract themes and synthesised findings using thematic content analysis. We used the Mixed Method Appraisal Tool (MMAT) version 2018 to assess the quality of included studies. We included 172 studies reporting on EDL and EML after screening 3,813 articles titles and abstracts and 1,545 full-text papers. Most (75%, n = 129) studies were purely quantitative in design, comprising descriptive cross-sectional designs (60%, n = 104), 15% (n = 26) were purely qualitative, and 10% (n = 17) had mixed-methods approaches. There were no qualitative or randomised experimental studies about EDL. The main barrier facing the EML and EDL was poorly equipped health facilities—including unavailability or stock-outs of essential in vitro diagnostics and medicines. Financial and non-financial incentives to health facilities and workers were key enablers in implementing the EML; however, their impact differed from one context to another. Only fifty-six (33%) of the included studies were of high quality. Poorly equipped and stocked health facilities remain an implementation barrier to essential diagnostics and medicines. Health system interventions such as financial and non-financial incentives to improve their availability can be applied in different contexts. More implementation study designs, such as experimental and qualitative studies, are required to evaluate the effectiveness of essential lists.
format Online
Article
Text
id pubmed-10121180
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-101211802023-04-22 Implementing essential diagnostics-learning from essential medicines: A scoping review Nyanchoka, Moriasi Mulaku, Mercy Nyagol, Bruce Owino, Eddy Johnson Kariuki, Simon Ochodo, Eleanor PLOS Glob Public Health Research Article The World Health Organization (WHO) model list of Essential In vitro Diagnostic (EDL) introduced in 2018 complements the established Essential Medicines List (EML) and improves its impact on advancing universal health coverage and better health outcomes. We conducted a scoping review of the literature on implementing the WHO essential lists in Africa to inform the implementation of the recently introduced EDL. We searched eight electronic databases for studies reporting on implementing the WHO EDL and EML in Africa. Two authors independently conducted study selection and data extraction, with disagreements resolved through discussion. We used the Supporting the Use of Research Evidence (SURE) framework to extract themes and synthesised findings using thematic content analysis. We used the Mixed Method Appraisal Tool (MMAT) version 2018 to assess the quality of included studies. We included 172 studies reporting on EDL and EML after screening 3,813 articles titles and abstracts and 1,545 full-text papers. Most (75%, n = 129) studies were purely quantitative in design, comprising descriptive cross-sectional designs (60%, n = 104), 15% (n = 26) were purely qualitative, and 10% (n = 17) had mixed-methods approaches. There were no qualitative or randomised experimental studies about EDL. The main barrier facing the EML and EDL was poorly equipped health facilities—including unavailability or stock-outs of essential in vitro diagnostics and medicines. Financial and non-financial incentives to health facilities and workers were key enablers in implementing the EML; however, their impact differed from one context to another. Only fifty-six (33%) of the included studies were of high quality. Poorly equipped and stocked health facilities remain an implementation barrier to essential diagnostics and medicines. Health system interventions such as financial and non-financial incentives to improve their availability can be applied in different contexts. More implementation study designs, such as experimental and qualitative studies, are required to evaluate the effectiveness of essential lists. Public Library of Science 2022-12-19 /pmc/articles/PMC10121180/ /pubmed/36962808 http://dx.doi.org/10.1371/journal.pgph.0000827 Text en © 2022 Nyanchoka et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Nyanchoka, Moriasi
Mulaku, Mercy
Nyagol, Bruce
Owino, Eddy Johnson
Kariuki, Simon
Ochodo, Eleanor
Implementing essential diagnostics-learning from essential medicines: A scoping review
title Implementing essential diagnostics-learning from essential medicines: A scoping review
title_full Implementing essential diagnostics-learning from essential medicines: A scoping review
title_fullStr Implementing essential diagnostics-learning from essential medicines: A scoping review
title_full_unstemmed Implementing essential diagnostics-learning from essential medicines: A scoping review
title_short Implementing essential diagnostics-learning from essential medicines: A scoping review
title_sort implementing essential diagnostics-learning from essential medicines: a scoping review
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121180/
https://www.ncbi.nlm.nih.gov/pubmed/36962808
http://dx.doi.org/10.1371/journal.pgph.0000827
work_keys_str_mv AT nyanchokamoriasi implementingessentialdiagnosticslearningfromessentialmedicinesascopingreview
AT mulakumercy implementingessentialdiagnosticslearningfromessentialmedicinesascopingreview
AT nyagolbruce implementingessentialdiagnosticslearningfromessentialmedicinesascopingreview
AT owinoeddyjohnson implementingessentialdiagnosticslearningfromessentialmedicinesascopingreview
AT kariukisimon implementingessentialdiagnosticslearningfromessentialmedicinesascopingreview
AT ochodoeleanor implementingessentialdiagnosticslearningfromessentialmedicinesascopingreview